Introduction
============

As the pharmacological treatment in Alzheimer disease (AD) is limited (Bauer, [@B6]), alternative therapeutic approaches are worth pursuing, such as non-invasive brain stimulation with transcranial direct current.

Transcranial direct current stimulation (tDCS) is the application of weak electrical currents by saline-soaked surface sponge electrodes to different cortical areas. tDCS can polarity-dependently modulate cortical excitability with prolonged after-effects (Nitsche et al., [@B57]) and modify neuronal excitability by tonic de-or hyperpolarization of the resting membrane potential (Creutzfeld et al., [@B14]; Purpura and McMurtry, [@B65]). The electrode positioning is determined according to the EEG 10--20 system.

tDCS has demonstrated efficacy in improving recognition memory in AD (Boggio et al., [@B11], [@B9]) and it is a useful tool in cognitive neurorehabilitation, as improvements in cognitive functions were described in patients with depression (Fregni et al., [@B29]), Parkinson's disease (Boggio et al., [@B10]) and stroke (Monti et al., [@B51]).

Alzheimer's disease is a progressive neurodegenerative disorder (Thies and Bleiler, [@B75]) presenting a decrease in acethylcholine activity resulting in cognitive impairment (Schliebs and Arendt, [@B69]) in many cognitive activities such as memory, language, and executive functions.

The concept of benefiting from modulating cortical excitability via tDCS with consecutive improvement in cognitive functions in AD is thus tempting. We describe tDCS application in clinical studies in patients with dementia (see Table [1](#T1){ref-type="table"}) and studies on cognitive functions (see Table [2](#T2){ref-type="table"}) as well as potential underlying mechanisms in this article.

###### 

**Clinical studies of tDCS in dementia**.

  Study                         Design                          *n*   Age (years)       Disease diagnosis                    MMSE             Medication          Parameters                             Brain target     Effect
  ----------------------------- ------------------------------- ----- ----------------- ------------------------------------ ---------------- ------------------- -------------------------------------- ---------------- ---------------------------------------------------------------
  **ALZHEIMER'S DISEASE**                                                                                                                                                                                                 
  Boggio et al. ([@B11])        Cross over, sham controlled     10    79 ± 9            NINCDS, ADRADA                       17 ± 5           AChEIs + others     Anodal/sham, 2 mA, 30 min              Left DLPFC       Improved visual recognition memory after atDCS
  Boggio et al. ([@B9])         Sham controlled                 15    78 ± 7, 81 ± 10   Adas-Cog, VRT, VAT, ADAS             21 ± 3, 19 ± 3   No data             Anodal, sham 2 mA, 30 min              TC bilateral     Improved visual recognition memory after atDCS
  Ferrucci et al. ([@B22])      Cross over, sham controlled     10    75 ± 7            DSM-IV, NINCDS- ADRADA               23 ± 2           AchEI               Anodal/cathodal/sham, 1.5 mA, 15 min   Left/right TPC   Accuracy of the word-recognition memory increased after atDCS
  **FRONTOTEMPORAL DEMENTIA**                                                                                                                                                                                             
  Huey et al. ([@B34])          Double-blind, sham controlled   10    61 (46−80)        Criteria Lund/Manchester 1994 MDRS   No data          AChEI + memantine   Active/sham, 2 mA, 20 min              FC               No improvement in verbal fluency after active tDCS

*AChEI, acetylcholine esterase inhibitors; Adas-Cog, Alzheimer's disease assessment scale-cognitive sub scale; ADAS, Alzheimer's disease assessment scale; DLPFC, dorsolateral prefrontal cortex; DSM- IV, Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV); FC, frontal cortex; MDRS, Mattis Dementia Rating Scale; MMSE, Mini Mental State Examination; NINCDS-ADRADA, National Institute of Neurological Communicative Disorders and Stroke-Alzheimer disease and Related Disorders Association; TC, temporal cortex; TPC, temporoparietal cortex; VAT, visual attention task; VRT, visual recognition task*.

###### 

**Studies of tDCS on cognitive functions**.

  Study                       Healthy subjects/age (age: mean \[± standard deviation\] or range)   Stimulation electrode                                            Polarity               Duration/intensity                         Side effects             Effects
  --------------------------- -------------------------------------------------------------------- ---------------------------------------------------------------- ---------------------- ------------------------------------------ ------------------------ -----------------------------------------------------------------------------------------------------------------------------------------------
  Andrews et al. ([@B2])      10, 20−51 years                                                      Left DLPFC                                                       Anodal/sham            10 min, 1 mA                               No                       Improvement in a WM task after atDCS
  Boggio et al. ([@B10])      18 Patients with PD, 45−71 years                                     M 1, left DLPC                                                   Anodal/sham            20 min, 1 or 2 mA                          No                       Improvement in WM of Parkinson's disease patients after atDCS of the left DLPFC
  de Vries et al. ([@B15])    38, 23 ± 2 years                                                     Broca's area                                                     Anodal/sham            20 min, 1 mA                               No                       atDCS facilitates the acquisition of grammatical knowledge
  Ferrucci et al. ([@B23])    13, 75 ± 7 years                                                     Cerebellum                                                       Anodal/cathodal/sham   15 min, 2 mA                               Headache (one patient)   atDCS and ctDCS impairs practice-dependent proficiency in WM
  Fiori et al. ([@B24])       10 Subjects, 3 patients, 45−70 years                                 Wernicke's area                                                  Anodal/sham            20 min, 1 mA                               No                       atDCS improved accuracy on the picture-naming task, both normal and patients had a shorter naming latency during atDCS
  Flöel et al. ([@B25])       19, 26 ± 3 years                                                     Cp5                                                              Anodal/cathodal/sham   20 min, 1 mA                               No                       Enhanced language learning by atDCS
  Flöel et al. ([@B26])       20, 62 ± 9 years                                                     Right temporoparietal cortex                                     Anodal/sham            20 min, 1 mA                               No                       Improved recall one week after learning with atDCS
  Fregni et al. ([@B28])      15, 19−22 years                                                      M1, DLPFC                                                        Anodal/cathodal/sham   10min, 1mA                                 No                       atDCS leads to enhancement of WM performance
  Iyer et al. ([@B36])        103, 19−70 years                                                     F3                                                               Anodal/cathodal/sham   20 min, 1 mA                               Skin redness             Enhanced verbal fluency by atDCS
  Javadi and Walsh ([@B37])   32, 23 ± 2 years                                                     Left DLPFC, M1                                                   Anodal/sham            20 min, 1 mA                               No                       Enhancement of verbal memorization after atDCS or impairment of verbal memorization after ctDCS
  Kincses et al. ([@B40])     22, 28 ± 5 years                                                     Fp3                                                              Anodal/cathodal        10 min, 1 mA                               No                       atDCS enhanced probabilistic classification learning
  Marshall et al. ([@B47])    13, 19−28 years                                                      F3 and F4                                                        Anodal/sham            Alternating 15 s off/15 s on over 30 min   No                       atDCS during slow wave sleep improves verbal declarative memory
  Marshall et al. ([@B48])    12, 19−27 years                                                      F3 and F4                                                        Anodal/cathodal        Alternating 15 s off/15 s on over 15 min   No                       Impaired performance in WM task by anodal and ctDCS
  Ohn et al. ([@B58])         15, 27 ± 4 years                                                     F3                                                               Anodal/sham            30 min, 1 mA                               No                       atDCS enhanced performance in a WM task
  Penolazzi et al. ([@B63])   11, 27 ± 5 years                                                     Right F4--C4, Left F3--C3, alternating between atDCS and ctDCS   Anodal/cathodal/sham   20 min, 1 mA                               No                       Right atDCS and left ctDCS facilitated the recall of pleasant images regarding pleasant and neutral images
  Ross et al. ([@B67])        14, 55−69 years                                                      Both anterior temporal lobes                                     Anodal/sham            15 min, 1.5 mA                             No                       Numerical improvement in face naming after atDCS
  Sparing et al. ([@B71])     15, 27 ± 4 years                                                     Cp5                                                              Anodal/cathodal/sham   7 min, 2 mA                                No                       Improved picture naming by atDCS
  Teo et al. ([@B74])         12, 27 ± 9 years                                                     F3 of the DLPFC                                                  Anodal/sham            20 min, 1 mA                               No                       Current strength may affect WM performance
  Zaehle et al. ([@B81])      10, 25 ± 2 years                                                     Left DLPFC                                                       Anodal/cathodal        15 min, 1 mA                               No                       Increase in WM performance and amplified oscillatory power in theta and alpha bands after atDCS, interference with WM performance after ctDCS

*Abbreviations for electrode placement according to the 10--20 electrode system (Cp5, Cz, Fp3, C3/4: see Recommendations for the practice of clinical. Neurophysiology: guidelines of the International Federation Clinical Neurophysiology. *Electroencephalogr. Clin. Neurophysiol. Suppl*. 1999;52:1--304), atDCS, anodal transcranial direct current stimulation; min, minutes, ctDCS, cathodal transcranial direct current stimulation, DLPFC, dorsolateral prefrontal cortex; mA, milli Ampere; min, minutes, PD, Parkinson's disease; TPC, temporoparietal cortex*.

Methodological Aspects
======================

The review section about the action mechanisms of tDCS in AD is based on a non-systematic approach, whereas the review section on clinical studies with tDCS in AD and memory is based on a somewhat systematic approach based on the PubMed database. A literature search for original and review articles on tDCS in demential disorders was performed through December 2011 seeking clinical studies on tDCS in AD and for demential disorders, by screening the PubMed database. The keywords were used in combination with "Alzheimer disease" AND "tDCS," "dementia" AND "tDCS" as well as "memory" AND "tDCS." The studies were published between 2004 and 12/2011. The exclusion criteria of articles in the article titles searched were only "brain stimulation," "depression," only "memory" or "Alzheimer disease," or "demential disorder" without "tDCS," "motor learning," and only "tDCS" without "memory" or "Alzheimer disease" or "demential disorder." Thirty-eight papers were screened from 75 articles according to the aforementioned criteria and 33 thereof were used as the basis for the Section ["tDCS in Demential Disorders."](#s1){ref-type="sec"}

tDCS in Demential Disorders {#s1}
===========================

Alzheimer's disease
-------------------

The effect of anodal tDCS (atDCS) over the left temporal cortex (TC) and dorsolateral prefrontal cortex (DLPFC) was investigated on recognition and working memory (WM) in 10 AD patients (Boggio et al., [@B11]), revealing enhancement in a visual recognition memory task after atDCS of the DLPFC and left TC (Boggio et al., [@B11]). In another study, an improvement in a word-recognition memory in 10 patients with probable AD was proven after atDCS of the temporoparietal areas (Ferrucci et al., [@B22]). In contrast, cathodal tDCS (ctDCS) lead to decreased word-recognition memory. The effect of atDCS persisted up to 30 min after stimulation, indicating a long-lasting increase in brain excitability (Ferrucci et al., [@B22]). Long-term enhancement of visual recognition memory for up to 4 weeks after therapy was found after atDCS in 15 AD patients (Boggio et al., [@B9]).

Frontotemporal dementia
-----------------------

A study demonstrated that active tDCS does not result in a beneficial effect in verbal fluency in 10 patients with frontotemporal dementia presenting mainly behavioral (and in one patient language) symptoms (Huey et al., [@B34]). The lack of effect may be due to the small current that reaches the frontal cortex due to brain atrophy and neuronal loss with concomitant incapability of the affected cortex to respond to brain polarization (Huey et al., [@B34]).

Safety and side effects of tDCS
-------------------------------

### General observations

There is evidence that tDCS applied to the scalp over the prefrontal cortex over 20 min does not alter local and global cortical function (Iyer et al., [@B36]). The current intensity of 1 mA did not result in significant effects on cortical function, whereas verbal fluency increased with 2 mA-atDCS and decreased with 2 mA-ctDCS (Iyer et al., [@B36]). In a systematic review, itching, tingling, headache, burning sensation, and discomfort were the most often reported adverse effects of active tDCS vs. sham tDCS (Brunoni et al., [@B12]). Skin irritation and skin burning can occur after tDCS application due to the electrochemical products' skin contact generated by the direct current (Durand et al., [@B20]; Palm et al., [@B59]). In addition, magnetic resonance spectroscopy (MRS) in normal subjects failed to detect changes in acetylaspartate, thus showing that atDCS induced no neurotoxic effects (Rango et al., [@B66]). Furthermore, in motor cortical areas, tDCS induced no relevant changes in serum neuron-specific enolase, a neuronal damage marker, indicating that tDCS induced no harmful effects (Nitsche et al., [@B55]).

### Observations in AD

In studies of tDCS in AD, no adverse effects from tDCS application were noted (Boggio et al., [@B11]). Only an itching sensation, but no side effects were reported in the study of 10 AD patients (Ferrucci et al., [@B22]). No adverse effects, nor tDCS effects on the Mini Mental State Examination (MMSE), Alzheimer's Disease Assessment Scale-Cognitive sub scale (Adas-Cog), or visual attention task (VAT) scores were observed (Boggio et al., [@B9]).

tDCS in Learning and Memory
===========================

Object-location learning in the elderly
---------------------------------------

The ability to memorize the location of objects is known to worsen by aging and in neurodegenerative dementia. atDCS over the temporoparietal cortex in 20 elderly healthy subjects resulted in improved retention of object-location learning for up to 1 week after learning (Flöel et al., [@B26]). This finding has relevance concerning memory deficits in normal and pathological aging.

Enhancing declarative memory by tDCS
------------------------------------

Anodal tDCS enhances slow oscillatory EEG activity that in turn can enhance declarative memories (Marshall et al., [@B47]). As shown in 32 human healthy subjects, declarative memory can be improved by anodal and impaired by ctDCS of the DLPFC (Javadi and Walsh, [@B37]).

Enhancing implicit memory by tDCS
---------------------------------

Both declarative and implicit memory are known to improve via tDCS. For instance, atDCS of Broca's area enhanced implicit learning of an artificial grammar in 38 healthy subjects (de Vries et al., [@B15]), an interesting finding supporting tDCS as a potential instrument in the rehabilitation of aphasic patients.

Modulation of WM by tDCS
========================

Enhancing WM by tDCS
--------------------

Several studies address the physiological effects of tDCS in the WM as a part of declarative memory playing a pivotal role in long-term memory, language, and executive function (Baddeley, [@B5]).

In 10 patients with cognitive defects after a first-ever stroke, atDCS of the DLPFC led to enhanced WM performance (Jo et al., [@B39]). In a neurodegenerative disease like Parkinson's, atDCS of the left DLPFC was also shown to improve WM in 18 patients (Boggio et al., [@B10]). atDCS to the DLPFC lead to WM enhancement in healthy subjects (Fregni et al., [@B28]; Andrews et al., [@B2]) and rats, frontal ctDCS enhanced visual--spatial WM (Dockery et al., [@B19]). Interestingly, atDCS led to amplified oscillation in theta and alpha electroencephalography (EEG) bands and increased WM performance in humans (Zaehle et al., [@B81]). WM representations are supported by oscillatory brain activity (Lisman and Idiart, [@B46]). In particular, theta EEG band activity has been associated with memory encoding and retrieval (Jensen and Tesche, [@B38]). Thus amplified theta band activity is related to WM's executive function, indicating the continuous information processing required during WM performance.

As neuroimaging studies revealed a widespread effect in cortical activity by tDCS (Lang et al., [@B44]), it is likely to imply a tDCS influence on the entire WM system, and not only on the DLPFC. Furthermore, there is some evidence that WM performance can be improved in a manner dependent on current strength in 14 healthy subjects (Teo et al., [@B74]). No current strength or time-course effect was observed in the accuracy of WM tasks. However, a significant current by time interaction was found in a WM task (Teo et al., [@B74]). However, the effect-dependence on current intensity of tDCS in memory function is not proven by this single study of one WM task; it requires further examination in healthy subjects and those with diverse cognitive functions.

A time-dependent enhancement of verbal memory resulted after atDCS of the DLPFC (Ohn et al., [@B58]). Name recall can benefit from atDCS of the anterior temporal lobes (Ross et al., [@B67]), and word retrieval improved in healthy and non-fluent aphasic patients after atDCS (Fiori et al., [@B24]).

Impairment of WM after tDCS
---------------------------

Bilateral prefrontal ctDCS and atDCS during a memory task can impair neuronal processes related to a WM paradigm (Marshall et al., [@B48]). Furthermore, cerebellar tDCS of both polarities impaired use-dependent improvement in a WM task (Ferrucci et al., [@B23]). WM also revealed impairment by ctDCS to the right parietal lobe (Berryhill et al., [@B7]).

Potential Mechanisms of Action of tDCS in AD
============================================

Effects of tDCS on neuronal activity by altering the membrane potential
-----------------------------------------------------------------------

In an AD mouse model, ß-amyloid peptide was shown to disturb the resting membrane potential in muscle fibers (Mukhamediarov et al., [@B52]). Furthermore, ß-amyloid 1--42 peptide caused membrane depolarization leading to hyperexcitability of affected neurons in a human neuronal cell model of AD (Blanchard et al., [@B8]).

atDCS might be an instrument to alter the neuronal depolarization frequently altered in AD according to *in vitro* studies, as atDCS leads to the increased cortical excitability promoting neuronal depolarization (Nitsche and Paulus, [@B56]). Increasing cortical excitability is a relevant tool in AD, as AD patients reveal temporoparietal hypoactivity (as characterized by focal slow wave activity in magnetoencephalography; Fernandez et al., [@B21]).

Motor cortex (Di Lazzaro et al., [@B17]) and global cortical hyperexcitability is found in AD (Rossini et al., [@B68]), correlating with cognitive severity in a TMS study (Alagona et al., [@B1]). As ctDCS led to reduced cortical excitability caused by neuronal hyperpolarization (Nitsche and Paulus, [@B56]), it might also be beneficial in AD by lowering its somewhat increased cortical excitability.

Non-synaptic mechanisms based on changes in the membrane potential underlying the after-effects of atDCS and ctDCS (Ardolino et al., [@B4]) might be responsible for modulating cognitive function in AD. The local changes in ionic concentrations could be due to alterations in transmembrane proteins and from changes in H+ ions induced by exposure to a constant electrical field (Ardolino et al., [@B4]).

Synaptic after-effects of tDCS
------------------------------

### NMDA receptor-dependent after-effects

tDCS induces prolonged after-effects sharing similarities with long-term potentiation (LTP)- and long-term depression (LTD)-like changes in cortical excitability (Paulus, [@B61]). In an *in vitro* and *in vivo* AD mouse model, LTP as the putative mechanism of learning and memory is evidently impaired by ß-amyloid peptide (Gengler et al., [@B31]; Middei et al., [@B49]). ß-amyloid peptide disruption of LTP is *N*-methyl-[d]{.smallcaps}-aspartate (NMDA) receptor-dependent in the mouse hippocampus *in vivo* and *in vitro* (Yamin, [@B79]).

tDCS-induced after-effects are partly NMDA receptor-dependent (Liebetanz et al., [@B45]), suggesting that tDCS after-effects may alter NMDA receptor-dependent cortical plasticity that may be disturbed in AD.

### GABAergic interneurons

Anodal after-effects are probably mediated in part by gamma-aminobutyric acid (GABA)~A~ergic interneurons as a reduction in short-interval intracortical inhibition and an increase in I-wave facilitation after tDCS intracortical facilitation (Nitsche et al., [@B57]; Stagg et al., [@B72]; Stagg and Nitsche, [@B73]). As in AD, GABAergic cortical inhibitory interneurons play a role in the disease's early stage (Koliatsos et al., [@B42]); modulation of these interneurons by tDCS is a possible disease-modifying mechanism. Hippocampus changes in GABA B receptor protein were found in 16 elderly subjects with AD, indicating alterations between the excitatory and inhibitory neurotransmitter systems with consecutively dysfunctional hippocampal circuitry (Iwakiri et al., [@B35]). A MRS study provides evidence that atDCS causes reduced GABA concentration within the stimulated cortex, whereas ctDCS leads to impaired glutamatergic neuronal activity with a correlated reduction in GABA concentration due to a relationship between these two neurotransmitters (Stagg et al., [@B72]). Thus tDCS might reduce the disequilibrium between excitatory and inhibitory neurotransmitters systems in AD.

### Glutamatergic synapses

In AD, glutamate receptors may be dysregulated by ß-amyloid accumulation resulting in the disrupted glutamatergic activity that coincides with cognitive decline (Parameshwaran et al., [@B60]). The dysregulation of glutamatergic activity might be altered by atDCS, as there is evidence that glutamatergic synapses are involved in anodal after-effects (Stagg et al., [@B72]; Stagg and Nitsche, [@B73]), and MRS data support that glutamate and glutamine levels were elevated in the parietal cortex after atDCS (Clark et al., [@B13]).

Therefore, ctDCS may have the potential to affect cognitive functions in AD by modulating glutamatergic synapses.

Effects of tDCS on human regional cerebral blood flow
-----------------------------------------------------

There is evidence in AD that characteristics of the cerebral microvasculature have changed, leading to altered cerebral blood flow (CBF; van Beek et al., [@B77]). atDCS induced an increase in regional cerebral blood flow (rCBF), whereas ctDCS resulted in a decrease in rCBF during and after stimulation (Zheng et al., [@B82]). As tDCS modulates CBF in many cortical and subcortical regions with sustained and widespread changes in neuronal activity (Lang et al., [@B44]), it is an auspicious instrument in AD.

Modulating oscillatory brain activity and functional connectivity pattern via tDCS
----------------------------------------------------------------------------------

AD led to an altered temporal correlation in parietal and prefrontal oscillations (Montez et al., [@B50]), more severe deceleration of spontaneous oscillatory activity (Rossini et al., [@B68]; de Waal et al., [@B16]), a functional disconnection (Gili et al., [@B32]), in particular between the prefrontal cortex and hippocampus in AD (Grady et al., [@B33]), and network connectivity changes (Zhou et al., [@B83]). It therefore makes sense to use tDCS as a therapeutic tool in AD, as it can reconfigure cerebral networks (Peña-Gómez et al., [@B62]) and cause changes in functional cerebral connectivity patterns suggesting alterations in brain synchronization (Polanía et al., [@B64]). As the cognitive dysfunction in brain diseases like AD is based on abnormal neural synchronization (Polanía et al., [@B64]), it may be beneficial to cause changes in brain synchronization via tDCS.

More specifically, atDCS over the primary motor cortex combined with inhibitory ctDCS of the contralateral frontopolar cortex caused an increased functional connectivity pattern within the premotor, motor, and sensorimotor areas of stimulated hemispheres in 10 healthy human subjects. Furthermore, intra- and interhemispheric connectivity changes became apparent after atDCS, indicating changes in brain topological functional organization (Uhlhaas and Singer, [@B76]). Another study demonstrated that ctDCS decreased while atDCS augmented normalized beta and gamma frequency EEG bands, suggesting transient reorganization of cortical activity (Antal et al., [@B3]). As gamma activity is also part of high-level information processing, it is an adjuvant method to influence higher-order cognitive function (Antal et al., [@B3]).

Modulating cortical neurotransmitters via tDCS
----------------------------------------------

Neuronal loss implicates the impairment of serotonergic neuromodulation as a basic mechanism of promoting dementia in AD (Yang et al., [@B80]). Furthermore, there is dopaminergic modulation of LTD-like plasticity in AD (Koch et al., [@B41]). Cholinergic systems with ascending projections are also degenerated in neurodegenerative dementia (Schmitt, [@B70]; Fregni et al., [@B29]). Modulating these neurotransmitter systems via tDCS would therefore seem to be a mechanism-based treatment of AD. Dopaminergic (Nitsche et al., [@B54]), serotonergic (Nitsche et al., [@B53]) and cholinergic (Kuo et al., [@B43]) neuromodulations have been demonstrated by atDCS and ctDCS (Stagg and Nitsche, [@B73]), indicating another disease-modifying treatment option of tDCS.

There are other mechanisms that determine the response of humans to tDCS, i.e., the BDNF polymorphism (Antal et al., [@B3]). BDNF modulation is an interesting target in AD, as ß-amyloid processing is involved in the BDNF pathway and (Forero et al., [@B27]) the BDNF ValMet 66 polymorphism is a neural risk for AD (Voineskos et al., [@B78]), suggesting BDNF as a factor shaping the cortical excitability response to tDCS in AD patients.

Limitations of Current Knowledge of tDCS in Demential Disorders
===============================================================

There are few studies on the effects of tDCS in demential disorders (AD and frontotemporal dementia, see Table [1](#T1){ref-type="table"}). The efficacy of tDCS in other demential disorders (for instance vascular dementia or Lewy body dementia) has thus not yet been proven. Furthermore, only a small battery of cognitive functions, i.e., selective attention, WM, visual and word-recognition memory, instruction remembering and word recall has been evaluated so far (see [tDCS in Demential Disorders](#s1){ref-type="sec"}). tDCS effects on other cognitive functions like calculating, cognitive flexibility, language, orientation, short- and long-term memory, and writing will have to be evaluated in studies with larger cohorts and longer control periods. The tDCS effects studied thus far are short-lived (maximum up to 1 month; Boggio et al., [@B9]) and there are no observations regarding longer-duration interventions. Nor have the long-term side effects of tDCS been assessed. This is particularly important, as tDCS applied over longer periods might interact with mechanisms involved in neurodegeneration with either beneficial (delayed deterioration of cognition) or harmful effects (accelerated cognitive deterioration). The interaction of tDCS with pharmacological treatment has not yet been addressed systematically in studies. However, current data indicate there is no significant interaction between medication outcome and its interaction with tDCS (Boggio et al., [@B9]).

Perspectives of tDCS in AD
==========================

tDCS may enhance our understanding of the neurobiological substrates underlying the cognitive decline in AD. Factors such as cognitive reserve, genetic variants, learning capacity, volumetric studies of cortical thinning and white matter volume, and integrity will have to be thoroughly and systematically investigated in future studies of tDCS on cortical functions in AD. The therapeutic efficacy of tDCS must be examined by outcome scales commonly used in trials of pharmacological agents such as the ADAS-Cog (Freitas et al., [@B30]). Moreover, multiple target tDCS or tDCS targeting new brain areas must be developed to overcome multiple cognitive deficits in AD. A multi-electrode stimulation set-up was recently demonstrated that increased focalty and intensity at the brain target (Dmochowksi et al., [@B18]).

Conclusions
===========

tDCS is an easy to perform and non-invasive alternative therapeutic tool for neurodegenerative diseases such as AD. Its effects comprise the enhancement of cognitive functions in explicit and implicit memory. The mechanisms of tDCS are based on changes in membrane polarization, cerebral blood flow, functional connectivity, and brain oscillatory activity that may be altered in AD and other demential disorders.
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